We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Newer Cardiac Imaging Technology Accurately Identifies Coronary Artery Stenosis

By MedImaging International staff writers
Posted on 22 Sep 2008
The first multicenter study of the accuracy of some of the latest cardiac imaging systems revealed that they were 99% effective in ruling out obstructive coronary artery stenosis (narrowing of these arteries) as compared with the more costly and invasive coronary angiography systems conventionally used by clinicians.

Matthew J. Budoff, M.D., a principal investigator at the Los Angeles Biomedical Research Institute at Harbor-the University of California, Los Angeles (UCLA) Medical Center (LA BioMed), is the lead investigator of the study conducted at 16 different sites with 230 research volunteers with chest pain but no known coronary artery disease.

"The research found this noninvasive method of cardiac imaging will effectively detect stenosis--a constriction or narrowing--of the coronary arteries which can lead to heart attacks and may require surgery to repair,” Dr. Budoff said. "This is good news for patients who, in the past, might have been forced to undergo a more expensive and invasive procedure to determine if they suffered from blockages in the arteries leading to their hearts.”

In the study, each of the research volunteers was evaluated using some of the newer cardiac computed tomography (CT) technology--electrocardiographically gated 64-multidetector row coronary CT angiography (CCTA). Each volunteer also underwent the more expensive and invasive coronary angiography, which is frequently called the "gold standard” for evaluating coronary artery stenosis.

The researchers discovered CCTA provided high diagnostic accuracy for detection of obstructive coronary stenosis at the thresholds of a 50% narrowing and at 70% stenosis. It also found CCTA was accurate 99% of the time in ruling out coronary artery stenosis.

The study was sponsored by GE Healthcare (Chalfont St. Giles, UK), which manufactures the cardiac CT imaging devices used in the study.

Related Links:
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center
GE Healthcare
Digital Intelligent Ferromagnetic Detector
Digital Ferromagnetic Detector
Adjustable Mobile Barrier
M-458
Ultrasonic Pocket Doppler
SD1
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro

Channels

General/Advanced Imaging

view channel
Image: The study developed a marker based on the analysis of routine CT scans of gastric cancer patients treated at UNICAMP. Higher radiodensity values for adipose tissue are linked to a worse prognosis. In contrast, higher values for muscle are linked to a more favorable outcome (Photo courtesy of FCM-UNICAMP)

CT-Derived Biomarker Predicts Outcomes in Gastric Cancer

Gastric cancer, also known as stomach cancer, is the fifth most common malignancy worldwide and often shows heterogeneous outcomes even within the same stage. Prognostic estimates typically rely on tumor-centric... Read more

Industry News

view channel
Image: MIM KineticID is 510(k)-pending software for dynamic PET imaging and kinetic modeling, enabling time-based radiotracer analysis for clinical and research decisions (Photo courtesy of GE Healthcare)

GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026

Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.